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IN previous publications we have reported significant elevation of nucleases,
adenosine deaminase and pyridine nucleotide-linked dehydrogenases in carcinoma
of the human cervix uteri (Goldberg and Pitts, 1966; Ayre and Goldberg, 1966).
These observations have been extended by study of another fibro-epithelial tissue
with specialised function in the human female. Since the chosen tissue-the
breast-is the site ofpathological changes other than malignancy, the opportunity
was taken to include these conditions within the scope ofthe investigation.
MATERIALS AND METHODS
Five samples of each of four histological types of human breast tissue were
examined:
Fibroadenomata.-These were removed as a solitary lesion from an otherwise
healthy breast. The samples examined contained proliferating cells predomi-
nantly of mesenchymal origin, with moderate hyperplasia of acinar tissue. These
changes were distributed throughout the lesion in a uniform manner. Three of
the specimens were pericanalicular fibroadenomata and 2 were intracanalicular.
Carcinomata.-One sample was a spheroidal cell carcinoma with pronounced
malignant features. Another was an intra-duct carcinoma showing early inva-
sion. The remaining 3 were scirrhous carcinomata displaying a moderate degree
of mitotic aberration. The line of demarcation between normal and abnormal
was imprecise, since none ofthe lesions was enc-apsulated. The sample cored out
for examination was as free from fat and reactive fibrous tissue as was possible
under the circumstances.
NOTE. The following abbreviations will be used in the text and tables:
RNA-ribonucleic acid
DNA-deoxyribonucleic acid
alk. and acid RNAase-alkaline and acid ribonuclease (EC 2.7.7.16)
DNAase I-deoxyribonuclease I (EC 3.1.4.5)
DNAase II-deoxyribonuclease II (EC 3.1.4.6)
ADase adenosine deaminase (EC 3.5.4.4)
LDH-lactate dehydrogenase (EC 1.1.1.27)
ICDH-isocitrate dehydrogenase (EC 1. 1. 1.42)
PGDH-phosphogluconate dehydrogenase (EC 1. 1. 1.44)
NAD-nicotinamide-adenine dinucleotide
NADP nicotinamide-adenine dinucleotide phosphate
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Fibrocystic disease.-The breast in these subjects was affected to a varying
degree by intraductal hyperplasia and papillomatosis, with cyst formation
accompanied by fibrous reaction and round-cell infiltration. The disease was
present to a varying extent in different parts ofthe same breast, and considerable
variations from one patient to another were noted. But in all the patients
studied a very severe degree ofinvolvement was present, and no part ofthe breast
could truly be described as normal. The sample cored out for examination was as
representative as possible.
Normnau8.-A small sample of predominantly acinar tissue was obtained
from the sub-areolar region ofpre-menopausal patients during removal ofsolitary
cysts or fibroadenomata. The breast in these subjects was essentially healthy.
The size ofthe sample was limited by ethical considerations.
Tissue preparation.-After removal from the patient, the samples were
dissected free offat and a block was cut for histological examination. They were
washed in ice-cold distilled water, dried on adsorbent paper, weighed, and stored
at -20° C. Approximately 1 week later, they were transferred to a freezing
microtome and cut into sections 20 microns thick before being homogenised in an
M.S.E. blender in 5 volumes of ice-cold 0-25 M sucrose for 3 minutes at maximal
speed. The homogenate was then strained through a single layer of muslin to
remove unbroken collagen fibres, and the liquor quantitatively separated into 3
cytoplasmic fractions as described previously (Goldberg and Pitts, 1966). A firm
layer offatfrequently formed above the unsedimented fraction during centrifuga-
tion, but this could readily be removed with a wooden spatula. Further treat-
ment ofthe fractions, and assay ofprotein and enzyme activities, were carried out
as described in our earlier reports (Goldberg and Pitts, 1966; Ayre and Goldberg,
1966).
RESULTS
The main problem encountered during this work was that of obtaining an
adequate yield of mitochondria and microsomes. This task was accomplished in
a minority ofthe specimens. Some ofthe particles were undoubtedly trapped by
collagen fibres during the straining procedure, and further losses must have
occurred during removal of the nuclei. Histological examination also revealed a
proportion of unbroken acinar cells, though most of the material resistant to
homogenisation was fibrous in nature. Prolongation of the homogenisation and
reduction in the thickness of sections cut in preparation for this step did not
increase the yield; and washing the nuclear pellet additional to the standard
procedure of a single wash failed to bring about any improvement.
TABLE I.-Protein Content ofSupernatant Fraction ofHuman Breast Tissue
Normal . . 22*0±1*2
Fibroadenorata . 19*1±2-6
Fibrocystic . . 15*4±1*4
Carcinomata . . 27-4±6- 6
Results as mg. protein per g. wet weight of tissue. Mean ± S.E. for 5 samples in each group.
Protein concentration
The supernatant fractioDs of normal breast and fibroadenomata were similar
with respect to protein concentration (Table I). The cancers showed a wider
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range with a higher mean value, but the difference was not significant. On the
other hand, the supernatant protein concentration of breast tissue in fibrocystic
diseasewas significantly lowerthanthat ofthe normalgroup (t = 3*67; p < 0.01).
The data for the mitochondrial and microsomal fractions were combined into
" malignant " and " non-malignant " groups for presentation in Table II. Al-
though too few results were available for a valid statistical comparison, they
tentatively suggest that the "malignant " samples were richer in mitochondria
and microsomes than the " non-malignant " samples, while in both groups the
mitochondria accounted for a greater percentage of the cytoplasmic protein than
the microsomes.
TABLE II.-Protein Content ofParticle Fractions ofHuman Breast Tissue
Non-malignant Malignant
r~~~~~ A
,
Mitochondria (5) Microsomes (3) Mitochondria (3) Microsomes (3)
Mean . 1-24 0 33 . 5-58 1-25
Range . 0-42-3*20 0 27-0O39 . 1 10-10 30 0 86-1*80
Results as mg. protein per g. wet weight of tissue. Number of samples in parenthesis.
Enzymes in supernatantfraction of breast tissue
The activities of all the enzymes studied are given as a function of protein
concentration and wet weight oftissue in Table III, and a statistical evaluation of
these results is presented in Table IV.
(a) Normal breast: The activity ofalk. RNAase exceeded that ofacid RNAase,
while DNAase II was more active than DNAase I. Moreover, the ability of the
samples to degrade RNA greatly exceeded their ability to degrade DNA. This
pattern of nuclease activity is similar to that found in the human cervix uteri
(Goldberg and Pitts, 1966). The dehydrogenases followed the pattern LDH>
ICDH>PGDH, in conformity with that of the cervix uteri (Ayre and Goldberg,
1966).
(b) Fibroadenomata: Except for alk. RNAase and PGDH, the activity ofeach
of the enzymes studied was moderately elevated in this group, but these changes
were not significant.
(c) Fibrocystic disease: With the exception of acid RNAase, the specific
activities of all the enzymes were raised in this condition. In 3 instances these
elevations were significantly above the normal levels-DNAase II (p < 0.01),
ADase (p < 0.05), and ICDH (p < 0.02). Because of the low soluble protein
content of the tissue, the activities relative to wet weight, while generally some-
what above the normal levels, were not significantly raised.
(d) Cancer: The specific activities of all the enzymes studied were higher in
the cancer tissue than in the normal samples. With the exception of DNAase I
and LDH, these elevations were statistically significant. These differences were
even more striking when enzyme activities were related to tissue weight; when this
parameter was used, DNAase I was the only enzyme which failed to show a
significant elevation in activity when compared with the normal levels.
Not only did the activities of the various enzymes found in the cancer tissue
exceed those of the normal samples (and likewise those of the fibroadenomata);
they were, with the exception of DNAase I activity, much above the levels
encountered in fibrocystic disease.
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TABLE III.-Enzyme Activities in Breast Tissue Supernatant
Alk. RNAase Acid RNAase
Units/mg. Protein Units/g. wet weight Units/mg. Protein Units/g. wet weight
Normal . . 16-4±5-2 345+109 . 10-5±2-6 222+57
Fibroadenomata . 21 6+442 433±115 . 12.3±2.4 257±81
Fibrocystic. . 24 0±50 369+86 . 7-6±1.8 216+91
Carcinomata . 56-2+12-0 1328±222 37.4±7-3 842±107
DNAase I
Units/mg. Protein Units/g. wet weight
Normal . . 0 37007 7-98±1-57
Fibroadenomata . 025±016 4-38±3- 18
Fibrocystic. . 0 66±0-15 9 70±1*90
Carcinomata . 038±011 9 49±2 * 96
ADase
Normal
Fibroadenomata.
Fibrocystic.
Carcinomata
Units/mg. Protein
132±21
186+49
290+62
546+31
Units/g. wet weight
2-99±0-52
3-72±0*94
4 73±1 32
14-82±3-28
DNAase II ~~~~~~A
Units/mg. Protein Units/g. wet weight
1-37+0-42 29-4± 8-4
1-57+0-72 31-2+13-1
394+054 62-1±13-6
6-56±1-69 179-5+41*6
LDH
Units/mg. Protein Units/g. wet weight
46+15 1250+353
87+21 1890+406
60+4 920+ 116
115+33 2610+368
ICDH PGDH
Units/mg. Protein Units/g. wet weight Units/mg. Protein Units/g. wet weight
Normal . . 10+3 230+62 . 2-3+0.6 51+10
Fibroadenomata. 21+6 480+152 . 2*3+0*8 51+15
Fibrocystic. . 28+5 430+103 2.8 1.7 48+25
Carcinomata . 41+7 1110+259 . 7-0±1-0 191+52
Mean + S.E. of 5 samples in each group. Nucleases as ug. nucleic acid phosphorus solubilised/
hour; dehydrogenases as mZm substrate transformed/min. at 250 C.; ADase as PM (mM) deami-
nated/hour/mg. protein (g. wet weight).
TABLE IV.-Comparative Statistical Evaluation of Enzyme Data for Breast Tissue
Su?pernatant
Fibrocystic v Normal Carcinomata v Normal
t P.< t P<
2 96 0-02
3-92 0.005
3-42 0.01
4 86 0.005
0 13
0 44
Alk. RNAase/mg. . 105 NS
Protein
Alk. RNAase/g. wet . 0- 17 NS
weight
Acid RNAase/mg. . 0 93 NS
Protein
Acid RNAase/g. wet . 006 NS
weight
DNAase I/mg. Protein. 1-77 NS
DNAase I/g. wet. . 0 68 NS
weight
DNAase II/mg. Protein 3 70 0 01
DNAase II/g. wet . 2 -25 NS
weight
ADase/mg. Protein 2-39 0-05
ADase/g. wet weight . 1-16 NS
LDH/mg. Protein . 083 NS
LDH/g. wet weight . 091 NS
ICDH/mg. Protein . 2-92 0-02
ICDH/g. wet weight . 091 NS
PGDH/mg. Protein . 1-59 NS
PGDH/g. wet weight . 1-52 NS
Data analysed according to Student's t-test.
Carcinomata v Fibrocystic
t
2-46 0.05
3.94
3 79
4-29
NS 1 46
NS 0*16
2-95 3 50
0-02 0.01
10-08
3 94
1*85
2-67
3-92
4-01
3-77
2-67
0- 001
0 005
NS
0-05
0-01
0-01
0-01
0 05
1-46
2-64
3-61
2 81
1 70
4-07
1 -21
2-18
1*82
2-16
0*005
0.01
0*005
NS
NS
NS
0 05
0.01
0-025
NS
0 005
NS
NS
NS
NS
NS = not significant.
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Enzyme activity of the particlefractions
The technique used for assay of ADase activity is not suitable for application
to turbid preparations and could not be used with this material. As with the
protein results, the data have been compiled under " malignant " and " non-
malignant " categories for the purpose of presentation in Table V. The particle
fractions from 2 samples of " malignant " and 2 of " non-malignant " tissue were
assayed for dehydrogenase activities. None of the 8 preparations so examined
contained detectable activity for LDH, ICDH or PGDH. Consequently the
data shown in Table V refer only to the nucleases. Because, relative to the other
estimations, much more material was needed for DNAase assays, results for these
enzymes were less frequently available.
The specific activities of all 4 nucleases were higher in the particle fractions
from malignant samples, but because of the high scatter associated with a small
number of results, statistical significance could not be demonstrated. As a con-
sequence of the low particulate protein content ofthe " non-malignant " samples,
these changes were magnified when enzyme activity was measured relative to
tissue weight, and the differences between the alk. and acid RNAase content of
the mitochondrial fractions were significant at the 0-1% (t 5.52) and 0-5%
(t = 4.29) levels respectively.
Only a very tentative comparison ofthe specific activities ofthe nucleases in the
particulate fractions with those in the supernatant is justified by the present work.
The activities ofboth RNAases are in the same range in all fractions ofthe tissues.
There is a suggestion that, relative to the corresponding supernatant, the particle-
bound DNAase I activity is greatly increased, while that of DNAase II is some-
what diminished, especially in the carcinomata.
TABLE V.-Nuclease Activities of Breast Tissue Particulate Fractions
Alk. RNAase Acid RNAase
Units/mg. Protein Units/g. wet weight Units/mg. Protein Units/g. wet weight
Non-malignant . (5) 15-2± 4-7 (5) 24-6+15-7 (5) 5-9± 2-4 (5) 6-4±2-1
Mitochondria
Malignant . . (3) 83-1±41-5 (3) 225-2±14-9 (3) 39-2±15-1 (3) 135-1±18-5
Mitochondria
Non-malignant . (3) 17-0 (3) 6-4 (3) 4-1 (3) 2-9
Microsomes
Malignant. (3) 68-4 (3) 106-5 (3) 26-9 (3) 38-6
Microsomes
DNAase I DNAase II
Units/mg. Protein Units/g. wet weight Units/mg. Protein Units/g. wet weight
Non-malignant . (2) 0-59 (2) 0-13 (2) 1-47 (2) 0-31
Mitochondria
Malignant . (2) 1-03 (2) 9.55 (2) 4-14 (2) 35-1
Mitochondria
Non-malignant . (1) 1- 01 (1) 0-24 (1) 1-56 (1) 0-32
Microsomes
Malignant . (2) 1-81 (2) 2-14 (2) 5-78 (2) 6-76
Microsomes
Mean values for each enzyme. S.E. given where relevant to statistical evaluation (see text).
Number of samples in parenthesis. Activities as defined in legend to Table III.
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DISCUSSION
In the non-malignant samples of breast tissue, the activity of RNA-splitting
enzymes was greater at pH 7*4 than at pH 5-6; the activity of DNAase II was
greater than that of DNAase I; the ability of the samples to degrade RNA was
greater than their DNA-splitting capacity; and the relative dehydrogenase
activities were, in order of diminishing capacity, LDH, ICDH, and PGDH. All
these properties were previously found in non-malignant samples of the human
cervix uteri (Goldberg and Pitts, 1966; Ayre and Goldberg, 1966), and it is possible
that this pattern is common to all human epithelial tissues.
The nature of the enzyme activities
The distribution of RNAase activities tentatively suggests certain differences.
In the non-malignant tissues supernatant acid RNAase activity was half that of
the corresponding alk. RNAase, while the particle-bound acid RNAase activity
was 3 that of the corresponding alk. RNAase. In the malignant tissues, these
ratios were 2 and 2 respectively. There is thus some evidence for a relative
decrease of acid RNAase in the particles. Since this enzyme is located in lyso-
somes in rat mammary gland (Greenbaum, Slater and Wang, 1960; Slater, 1961)
the rupture of these particles by freezing and thawing with solubilisation of acid
RNAase may be presumed. The alk. RNAase of rat mammary gland has been
reported to be of mitochondrial origin (Slater, 1961). Freezing and thawing
might be expected to have a less pronounced effect on such particles, and this
would account for the higher relative particle-bound activity ofthis enzyme in the
present material.
DNAase I specific activity was greater in the particle fractions, while that of
DNAase II was higher in the supernatant. There seems little doubt that these
activities are due to different enzyme components. Although DNAase II activity
is associated with lysosomes in most tissues (De Duve, Wattiaux and Baudhuin,
1962), this does not appear to be so in rat mammary gland (Greenbaum et al.,
1960), and it is probable that likewise in the corresponding human tissue the bulk
ofthe enzyme is of supernatant origin. We have been unable to detect dehydro-
genase activity other than in the supernatant fraction ofhuman mammary tissue.
Relationship between enzyme chuxnges and tissue pathology
For all the enzymes studied, the breast tissues, with few exceptions, showed a
general increase in supernatant activity in the following order: normal, fibro-
adenomata, fibrocystic, and carcinoma. A precise evaluation of the extent to
which these changes represent genuine increases in enzyme content of the acinar
cells is not possible. At least two other cell types were present in the material:
fat cells and connective tissue cells. The former were relatively minor con-
stituents, and while the latter were abundant in all samples, it was our impression
from histological examination that the amount of fibrous tissue bore an inverse
relationship to the soluble protein content as estimated by chemical analysis.
Indeed the well-known insolubility of collagen and of connective tissue com-
ponents in general (Eastoe and Courts, 1963) renders it probable that the bulk of
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thesoluble protein was derived from the acinar cells, and that the specific enzyme
activities offer a useful guide to the enzyme content of the epithelial cells.
If this reasoning is correct, we may state that increased nuclease, adenosine deaminase and dehydrogenase content of the human mammary epithelial cell takes place during the transition from the normal state to hyperplastic and neo- plastic states, this increase being greatest when the stage of invasive carcinoma is attained. Although scanty, the data on particle-bound nuclease activity support the idea that we are dealing with genuine differences between cells of epithelial
type, since it is likely that contamination of this material by non-epithelial elementswould be even less than that possible for the corresponding supernatants.
The biochemical changes found in breast cancers were similar to those that distinguish malignant from non-malignant cervix uteri (Goldberg and Pitts,
1966; Ayre and Goldberg, 1966) and may be characteristic of human epithelial
cancers. The increased levels of nucleic acid-splitting enzymes may form part of
the invasive apparatus of the cancer cells. Many reports testify to the high content of nucleases that develops in cells subjected to viral invasion (Wormser
and Pardee, 1957; Korn and Weissbach, 1963; Keir and Gold, 1963; Russell
et al., 1964). A correlation between virulence and DNAase activity has been
established for certain bacteria (Jacobs, Willis and Goodburn, 1963); and
impairment of various metabolic functions, especially protein synthesis and oxidative phosphorylation, has been demonstrated after addition of pancreatic
RNAase to cells growing in culture (Firket, Chevremont-Comhaire and Chevre-
mont, 1955; Groth, 1956; Hanson, 1959; Jeener, 1959a, 1959b; Jeener, Dupont-
Mairesse and Vansanten, 1960). The pronounced increase in the NADP-linked
dehydrogenases, in contrast to the relatively minor change in activity of the NAD--linkedLDH, is compatible with the suggestion ofPotter (1956) that cancers mayhave increased capacity for generating reduced NADP required for synthesis
of thymidine, which step is probably rate-limiting for DNA synthesis.
It is interesting that the fibroadenomata, which do not give rise to cancers,
showed no significant differences when compared with normal breast tissue, while
the samples removed from breasts with fibrocystic disease differed from the
normal in several respects; these changes were in the same direction as those
found in the cancer tissue but of less pronounced degree. From the standpoint
of this investigation, fibrocystic disease would seem to occupy an enzymological
position midway between normal and malignant tissue. This would fit with its
status as a pre-malignant lesion (Willis, 1960; Sandison, 1962; Davis, Simons
and Davis, 1964). It may be noted that all the samples were the site of epithelial
hyperplasia, although the proportion of fibrous tissue present was greater than
that encountered in the other conditions, thus accounting for the low soluble
protein content of the tissues. Since Sandison(1962) considers epithelial hyperplasia of the type seen in all 5
samples with fibrocystic disease to be the key pathological change in the involuting
breast, it is interesting that forced mammary involution in the rat is accompanied
by an early rise in activity of acid hydrolases, including RNAase (Greenbaum, Slater and Wang, 1965), while the catabolism of glucose by the various pathways
is reduced (Greenbaum and Darby, 1964), and thus it is unlikely that the activities
of the enzymes concerned could be raised. This pattern of increased nuclease
activity and unchanged dehydrogenase activity is precisely that seen in the present
fibrocystic material.
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Present work in relation to previous reports
Our results in human mammary cancer contrast with those of Daoust and
Amano (1963) who reported decreased RNAase and DNAase activity in material
studied by histochemical techniques. These findings have been criticised by Roth
(1963), but examination ofrat liver tumours by an immunofluorescence technique
supports the conclusions derived from histochemical analysis of RNAase in this
tissue (Gordon and MIyers, 1966). It must be pointed out, however, that changes
in the characteristics of these enzymes can occur during malignancy, as reported
by Colter, Kuhn and Ellem (1961) for RNAases of mouse ascites tumours, and by
Georgatsos and Symeonidis (1965) for DNAases of mouse mammary tumours.
It is not unreasonable to suggest that the above techniques are, in their present
state of development, not yet capable of providing the sensitivity and precision
possessed by the conventional methods used in this study.
Measurements of dehydrogenases have been reported in various rodent
tumours. The activities of 3 NADP-linked enzymes, including ICDH, were
increased in experimental rat mammary tumours (Hilfet al., 1965), but changes in
ICDH were found less frequently in response to endocrine ablation or hormone
treatment (Hilf et at., 1966). Increased production of lactate from glucose takes
place in the Barrett mammary adenocarcinoma of mice (Abraham and Chaikoff,
1965). This tumour has a higher content of LDH and a lower content of hexose
monophosphate shunt enzymes than normal mouse mammary tissue, whereas
pre-neoplastic alveolar nodules ofbreast have lower LDH than normal and higher
levels of hexose monophosphate shunt enzymes than the cancers (Kopelovich
et al., 1966). Rat mammary tumours induced by 3-methylcholanthrene had
increased LDH and ICDH relative to wet weight and protein content, but of the
2, only LDH was increased relative to DNA-phosphorus (Hershey et al., 1966).
There is thus ample precedence for increased ICDH in mammary tumours, but
the relative insensitivity ofLDH and the significant increase in PGDH activity in
the human tumours contrast with the above reports on rodent tumours.
The paucity of cytoplasmic particles found in the non-malignant samples in
this study is consistentwith severalreportsbased onelectronmicroscopy. Normal
resting human breast tissue contains only 5-13 mitochondria per cell and is
essentially devoid of rough-surfaced ergastoplasm (Waugh and Van der Hoeven,
1962). The fine structure of the cells in fibrocystic disease resembles that of
normal breast cells (Wellings and Roberts, 1963). Breast cancers show con-
siderable variation in their ultrastructure, but in general it would appear that
medullary carcinomas and mucin-producing carcinomas have abundant mito-
chondria and well-developed endoplasmic reticulum, whereas these structures are
less well represented in scirrhous cancers (Wellings and Roberts, 1963; Murad and
Scarpelli, 1965; Tellem et al., 1966). A direct quantitative comparison between
the cytoplasmic particle content ofnormal and malignant human breast does not
seem to have been made. The question of whether the differences in particle
protein content between malignant and non-malignant breast tissue as recorded
in the present work represent technical difficulties or genuine differences in
cellular ultrastructure can only be answered by direct counting; such a technique
has been successfully applied to the rat mammary gland, and has elucidated
certain aspects of lactation and involution in this organ (Greenbaum and Slater,
1957).
319320 D. M. GOLDBERG, JANET F. PITTS AND HEATHER A. AYRE
SUMMARY
(1) The activities of alkaline and acid ribonuclease, deoxyribonuclease II
(DNAase II) and adenosine deaminase (ADase) were greater relative to wet weight
and protein content in the supernatant fraction of human breast cancers as
compared with the corresponding activities in non-malignant human breast
tissue. DNAase I activity was of the same order in the supernatant fractions of
malignant and non-malignant samples.
(2) The activities of lactate dehydrogenase, isocitrate dehydrogenase (ICDH)
and phosphogluconate dehydrogenase were higher, relative to wet weight, in the
supernatant fraction of the cancers than the corresponding activities in normal
breast tissue. The latter 2 activities were also higher in the cancers relative to
protein content. None of these enzymes could be detected in cytoplasmic
particulate fractions prepared from malignant and non-malignant breast tissue.
(3) The activities of all these enzymes in breast fibroadenomata were, for the
most part, a little higher than those ofthe normal breast tissue, but none ofthese
differences were significant. By contrast, tissue from cases of fibrocystic disease
had levels which were generally midway between those of the normal and cancer
tissues, and the specific activities of DNAase II, ADase and ICDH relative to
protein were significantly higher than the normal levels.
(4) The supernatant protein content of the samples showed an inverse rela-
tionship to the proportion of fibrous tissue present, the value for the fibrocystic
samples being significantly below the normal level.
(5) Cytoplasmic particulate fractions were prepared from a small series of
malignant and non-malignant tissues. The nuclease activities of the malignant
samples exceeded those of the non-malignant samples, and the protein content of
the former exceeded that ofthe latter.
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